VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,455,407 | -24.3% | 3,277,180 | +7.0% | 0.00% | -33.3% |
| Q2 2023 | $57,431,850 | +18.9% | 3,063,032 | -8.6% | 0.00% | 0.0% |
| Q1 2023 | $48,303,784 | -72.1% | 3,349,777 | -62.5% | 0.00% | -40.0% |
| Q4 2022 | $173,029,596 | +79.9% | 8,942,098 | +219.4% | 0.01% | -16.7% |
| Q3 2022 | $96,174,000 | +939.8% | 2,799,834 | +362.6% | 0.01% | +500.0% |
| Q2 2022 | $9,249,000 | -84.8% | 605,283 | -77.3% | 0.00% | -66.7% |
| Q1 2022 | $60,772,000 | -6.5% | 2,663,106 | +51.0% | 0.00% | 0.0% |
| Q4 2021 | $65,015,000 | +478.8% | 1,763,364 | +637.8% | 0.00% | +200.0% |
| Q3 2021 | $11,233,000 | – | 239,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |